Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

The cationic cytokine IL-26 differentially modulates virus infection in culture.

Braum O, Klages M, Fickenscher H.

PLoS One. 2013 Jul 10;8(7):e70281. doi: 10.1371/journal.pone.0070281. Print 2013.

2.

Protection from RNA and DNA viruses by IL-32.

Zepp JA, Nold-Petry CA, Dinarello CA, Nold MF.

J Immunol. 2011 Apr 1;186(7):4110-8. doi: 10.4049/jimmunol.1000081. Epub 2011 Feb 23.

3.

Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.

Broberg EK, Peltoniemi J, Nygårdas M, Vahlberg T, Röyttä M, Hukkanen V.

J Virol. 2004 Dec;78(23):13139-52.

4.
5.
6.

Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1.

Halford WP, Gebhardt BM, Carr DJ.

J Immunol. 1996 Oct 15;157(8):3542-9.

PMID:
8871654
8.

Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice.

Steinhoff U, Müller U, Schertler A, Hengartner H, Aguet M, Zinkernagel RM.

J Virol. 1995 Apr;69(4):2153-8.

9.

Virucidal activity presence in Trichilia glabra leaves.

Cella M, Riva DA, Coulombié FC, Mersich SE.

Rev Argent Microbiol. 2004 Jul-Sep;36(3):136-8.

PMID:
15559196
10.

In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).

Zhang XM, He DN, Zhou B, Pang R, Liu K, Zhao J, Chen PY.

Antiviral Res. 2013 Aug;99(2):149-57. doi: 10.1016/j.antiviral.2013.05.009. Epub 2013 May 28.

PMID:
23727591
11.

Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.

Drescher KM, Whittum-Hudson JA.

Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2302-12.

PMID:
8843914
12.

IL-12 is not required for induction of type 1 cytokine responses in viral infections.

Oxenius A, Karrer U, Zinkernagel RM, Hengartner H.

J Immunol. 1999 Jan 15;162(2):965-73.

13.

Effect of black tea extract on herpes simplex virus-1 infection of cultured cells.

Cantatore A, Randall SD, Traum D, Adams SD.

BMC Complement Altern Med. 2013 Jun 18;13:139. doi: 10.1186/1472-6882-13-139.

14.

Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.

Ghiasi H, Osorio Y, Hedvat Y, Perng GC, Nesburn AB, Wechsler SL.

Virology. 2002 Oct 10;302(1):144-54.

15.

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.

Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.

Cancer Res. 2001 Apr 1;61(7):2983-95.

16.

Effect of viral infections on the ability of human endothelium for interferon, tumor necrosis factor and interleukin 6 production.

Zaczyńska E, Błach-Olszewska Z, Sender J, Jarosz W.

Arch Immunol Ther Exp (Warsz). 1997;45(2-3):243-7.

PMID:
9597094
17.
18.

A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors.

Corrales-Aguilar E, Trilling M, Reinhard H, Mercé-Maldonado E, Widera M, Schaal H, Zimmermann A, Mandelboim O, Hengel H.

J Immunol Methods. 2013 Jan 31;387(1-2):21-35. doi: 10.1016/j.jim.2012.09.006. Epub 2012 Sep 27.

PMID:
23023090
19.

Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.

Fukushi S, Mizutani T, Saijo M, Matsuyama S, Miyajima N, Taguchi F, Itamura S, Kurane I, Morikawa S.

J Gen Virol. 2005 Aug;86(Pt 8):2269-74.

PMID:
16033974

Supplemental Content

Support Center